Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MI-3454 | 2134169-43-8 | 98.03% | 636.73 | 100 MG
SDP

Catalog No. 5000349002
Encompass_Preferred

MI-3454 is an orally active, potent, and selective menin-MLL1 interaction inhibitor with an IC50 of 0.51 nM. It inhibits proliferation, induces differentiation, and leads to leukemia regression in mouse models of MLL1-rearranged or NPM1-mutated leukemia by downregulating key genes.

  • Inhibits proliferation of murine bone marrow cells transformed with MLL-AF9 or Hoxa9/Meis1.
  • Downregulates HOXA9 and MEIS1 expression in human leukemic cell lines.
  • Reduces viability of leukemic cells with MLL fusion proteins (GI50 7-27 nM).
  • Blocks menin-MLL1 interaction.
  • Does not potently inhibit cytochromes P450.
  • Induces remission or regression of leukemia in MLL1-rearranged or NPM1-mutated mouse models.
  • Exhibits favorable stability in murine and human liver microsomes.
  • Shows limited ability to cross the blood-brain barrier.

Catalog No. 50-003-49002 Supplier Medchemexpress LLC Supplier No. HY136360100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MI-3454 is an orally active, potent, and selective menin-MLL1 interaction inhibitor with an IC50 of 0.51 nM. It inhibits proliferation, induces differentiation, and leads to leukemia regression in mouse models of MLL1-rearranged or NPM1-mutated leukemia by downregulating key genes.

  • Inhibits proliferation of murine bone marrow cells transformed with MLL-AF9 or Hoxa9/Meis1.
  • Downregulates HOXA9 and MEIS1 expression in human leukemic cell lines.
  • Reduces viability of leukemic cells with MLL fusion proteins (GI50 7-27 nM).
  • Blocks menin-MLL1 interaction.
  • Does not potently inhibit cytochromes P450.
  • Induces remission or regression of leukemia in MLL1-rearranged or NPM1-mutated mouse models.
  • Exhibits favorable stability in murine and human liver microsomes.
  • Shows limited ability to cross the blood-brain barrier.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.